In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

For the clinical trials, the capsule was loaded with risperidone, a commonly prescribed medication used to treat schizophrenia. Most patients take the drug orally once a day.